PFIZER AND BIONTECH TO PROVIDE 500 MILLION DOSES OF COVID-19 VACCINE TO U.S. GOVERNMENT FOR DONATION TO POOREST NATIONS

  • U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022
  • Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility
  • Effort is part of the companies’ recent pledge of two billion doses to ensure global equitable access to the vaccine

Continue reading

Accelerate Diagnostics Receives CARB-X Award to Develop Rapid Optical Imaging Technology for Sepsis and Antibiotic-Resistant Infections

CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), a global non-profit partnership dedicated to accelerating research and development to address the rising global threat of drug-resistant bacteria, has awarded Accelerate Diagnostics up to $578,000 to develop new fiber optic technology to diagnose sepsis or the risk of sepsis. Accelerate would be eligible for up to $2.1 million in additional funds from CARB-X if the project meets certain milestones.Continue reading

Astroskin First Flight with Virgin Galactic and Kellie Gerardi

Washington, DC, USA (June 3rd, 2021): Virgin Galactic has announced a new contract to fly International Institute of Astronautical Sciences (IIAS) researcher Kellie Gerardi on a test flight of the company’s spaceflight system, during which Kellie will conduct experiments and test new healthcare technologies (including the Astroskin Bio-Monitor) while she’s in space. Continue reading

Phoenix Innovators are Driving Translational Discovery

It is challenging to find anyone who has not had their life impacted by cancer, a debilitating illness, or a degenerative condition.  These diseases affect not only the patient’s life, but those of their families and their surrounding community. The advancement of medicine is changing this trajectory, and that advancement will go right through Phoenix.Continue reading